35岁以上唐氏综合征成人中痴呆与死亡风险的关联
这项在英格兰社区开展的前瞻性纵向研究纳入211名36岁及以上唐氏综合征成人,随访503.92人年,发现31.3%有临床痴呆诊断,痴呆者粗死亡率为1191.85/万人年,约为无痴呆者的5倍;痴呆者中APOE ε4携带者死亡风险升高(HR 6.91),无痴呆者中36岁后起病的癫痫与死亡相关(HR 9.66)。
要点
- 唐氏综合征成人中痴呆与死亡率升高相关,70%的死亡者患有痴呆。
- 痴呆者中APOE ε4携带者死亡风险升高(HR 6.91)。
- 无痴呆者中晚发癫痫(36岁后起病)与死亡相关(HR 9.66)。
核心结论
- 痴呆与70%的唐氏综合征老年人死亡相关。
- APOE ε4携带者和/或多种健康共病者痴呆和死亡风险增加,突出良好医疗保健的需求。
- 在无痴呆诊断的死亡者中,晚发性癫痫是唯一与死亡显著相关的因素,提示该群体可能存在未诊断的痴呆病例。
研究设计与样本
- 前瞻性纵向研究,社区设置,英格兰,数据收集始于2012年3月29日,病例删失于2017年12月13日。
- 潜在样本为伦敦唐氏综合征联盟队列中36岁及以上、有2个数据时间点且记录痴呆状态的成人(N=300);6人退出研究,28人失访,55人在分析时仅有单个数据收集点。
- 最终样本211名参与者,随访503.92人年。
主要发现
- 211名参与者中96名为女性(45.5%),66名(31.3%)有临床痴呆诊断。
- 27名参与者(11名女性;平均死亡年龄56.74岁)在研究期间死亡,其中70%患有痴呆。
- 痴呆者粗死亡率为1191.85/万人年(95% CI 1168.49-1215.21),约为无痴呆者232.22/万人年(95% CI 227.67-236.77)的5倍。
- 痴呆者中APOE ε4携带者死亡风险升高(HR 6.91,95% CI 1.756-27.195)。
- 无痴呆者中36岁后起病的癫痫与死亡相关(HR 9.66,95% CI 1.59-58.56)。
关键数值与推荐
- APOE ε4携带者(HR 4.91,95% CI 2.53-9.56)、早发性癫痫成人(HR 3.61,95% CI 1.12-11.60)、多种健康共病(HR 1.956,95% CI 1.087-3.519)和与家庭同住者(HR 2.14,95% CI 1.08-4.20)获得显著更早的痴呆诊断。
临床怎么用
- 作者认为APOE ε4携带者和/或多种健康共病者痴呆和死亡风险增加,突出良好医疗保健的需求。
- 作者提出对于无痴呆诊断的死亡者,晚发性癫痫是唯一与死亡显著相关的因素,并对该群体中可能未诊断的痴呆病例提出疑问。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: This work quantifies the fatal burden of dementia associated with Alzheimer disease in individuals with Down syndrome (DS). OBJECTIVE: To explore the association of dementia associated with Alzheimer disease with mortality and examine factors associated with dementia in adults with DS. DESIGN, SETTINGS AND PARTICIPANTS: Prospective longitudinal study in a community setting in England. Data collection began March 29, 2012. Cases were censored on December 13, 2017. The potential sample consisted of all adults 36 years and older from the London Down Syndrome Consortium cohort with 2 data times and dementia status recorded (N = 300); 6 withdrew from study, 28 were lost to follow-up, and 55 had a single data collection point at time of analysis. The final sample consisted of 211 participants, with 503.92 person-years' follow-up. EXPOSURES: Dementia status, age, sex, APOE genotype, level of intellectual disability, health variables, and living situation. MAIN OUTCOMES AND MEASURES: Crude mortality rates, time to death, and time to dementia diagnosis with proportional hazards of predictors. RESULTS: Of the 211 participants, 96 were women (45.5%) and 66 (31.3%) had a clinical dementia diagnosis. Twenty-seven participants (11 female; mean age at death, 56.74 years) died during the study period. Seventy percent had dementia. Crude mortality rates for individuals with dementia (1191.85 deaths per 10 000 person-years; 95% CI, 1168.49-1215.21) were 5 times higher than for those without (232.22 deaths per 10 000 person-years; 95% CI, 227.67-236.77). For those with dementia, APOE ε4 carriers had a 7-fold increased risk of death (hazard ratio [HR], 6.91; 95% CI, 1.756-27.195). For those without dementia, epilepsy with onset after age 36 years was associated with mortality (HR, 9.66; 95% CI, 1.59-58.56). APOE ε4 carriers (HR, 4.91; 95% CI, 2.53-9.56), adults with early-onset epilepsy (HR, 3.61; 95% CI, 1.12-11.60), multiple health comorbidities (HR, 1.956; 95% CI, 1.087-3.519), and those living with family (HR, 2.14; 95% CI, 1.08-4.20) received significantly earlier dementia diagnoses. CONCLUSIONS AND RELEVANCE: Dementia was associated with mortality in 70% of older adults with DS. APOE ε4 carriers and/or people with multiple comorbid health conditions were at increased risk of dementia and death, highlighting the need for good health care. For those who died without a dementia diagnosis, late-onset epilepsy was the only significant factor associated with death, raising questions about potentially undiagnosed dementia cases in this group.
引用
- Hithersay R, Startin CM, Hamburg S, et al. Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years. JAMA Neurol. 2019. PMID: 30452522. doi:10.1001/jamaneurol.2018.3616
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。